FLUOXETINE

FLUOXETINE was reported 128596 times

FLUOXETINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 45 0.4688
1 ANTIDEPRESSANT DRUG LEVEL INCREASED 72 0.2028
2 PROLONGED EXPIRATION 44 0.1679
3 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 106 0.1534
4 SEROTONIN SYNDROME 1761 0.0916
5 DISINHIBITION 136 0.0844
6 BEZOAR 110 0.0797
7 AMAUROSIS FUGAX 82 0.0761
8 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 135 0.0683
9 PARASOMNIA 47 0.0654
10 INTRUSIVE THOUGHTS 70 0.0594
11 AGITATION NEONATAL 51 0.0532
12 OCULOGYRIC CRISIS 108 0.0503
13 CLONUS 129 0.0471
14 ANTIPSYCHOTIC DRUG LEVEL INCREASED 132 0.0468
15 BINGE EATING 50 0.0463
16 HYPERREFLEXIA 159 0.0456
17 SUSPECTED SUICIDE 204 0.0435
18 ANORGASMIA 113 0.0416
19 VASOPLEGIA SYNDROME 65 0.0396
20 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 199 0.0388
21 ACCIDENTAL DEATH 72 0.0387
22 SUICIDAL BEHAVIOUR 159 0.0382
23 OBSESSIVE-COMPULSIVE DISORDER 301 0.0375
24 TORSADE DE POINTES 291 0.0371
25 COMPLETED SUICIDE 3012 0.0361
26 INTENTIONAL SELF-INJURY 714 0.0353
27 BRADYPNOEA 95 0.0352
28 ALCOHOL INTERACTION 68 0.0350
29 INTENTIONAL OVERDOSE 2145 0.0334
30 SELF-INJURIOUS IDEATION 138 0.0329
31 HYPERSEXUALITY 60 0.0328
32 COMA SCALE ABNORMAL 95 0.0328
33 INHIBITORY DRUG INTERACTION 51 0.0322
34 HOMICIDE 59 0.0320
35 AKATHISIA 429 0.0314
36 PHYSICAL DECONDITIONING 80 0.0311
37 REBOUND ACID HYPERSECRETION 93 0.0307
38 POISONING 383 0.0305
39 SCHIZOAFFECTIVE DISORDER 53 0.0297
40 LONG QT SYNDROME 71 0.0296
41 MULTIPLE DRUG OVERDOSE INTENTIONAL 94 0.0292
42 TEARFULNESS 125 0.0290
43 ELECTROCARDIOGRAM QT PROLONGED 1029 0.0286
44 EMOTIONAL POVERTY 50 0.0285
45 MAJOR DEPRESSION 208 0.0284
46 DEPRESSIVE SYMPTOM 100 0.0283
47 CONVERSION DISORDER 54 0.0278
48 IMPULSIVE BEHAVIOUR 104 0.0277
49 HYPOGLYCAEMIA NEONATAL 44 0.0272
50 NEPHROGENIC ANAEMIA 126 0.0272
51 DISTRIBUTIVE SHOCK 60 0.0265
52 SUICIDE ATTEMPT 1603 0.0264
53 MULTIPLE DRUG OVERDOSE 128 0.0258
54 THERAPEUTIC PRODUCT EFFECT VARIABLE 100 0.0257
55 POISONING DELIBERATE 242 0.0255
56 GAMBLING DISORDER 68 0.0251
57 NEGATIVE THOUGHTS 72 0.0246
58 RESPIRATORY DEPRESSION 300 0.0245
59 SEDATION COMPLICATION 62 0.0243
60 CATATONIA 127 0.0242
61 TORTICOLLIS 51 0.0240
62 HYPERPARATHYROIDISM SECONDARY 60 0.0239
63 AUTONOMIC NERVOUS SYSTEM IMBALANCE 69 0.0236
64 ATRIOVENTRICULAR BLOCK FIRST DEGREE 101 0.0233
65 LABYRINTHITIS 58 0.0229
66 DEREALISATION 49 0.0228
67 TIC 124 0.0227
68 FEELING OF DESPAIR 106 0.0227
69 MYOCLONUS 270 0.0226
70 ALCOHOL POISONING 60 0.0224
71 GENERALISED TONIC-CLONIC SEIZURE 370 0.0223
72 LIBIDO INCREASED 45 0.0222
73 DRUG INTERACTION 3515 0.0221
74 PRIAPISM 76 0.0220
75 FLAT AFFECT 51 0.0220
76 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 49 0.0219
77 COMPULSIVE SHOPPING 45 0.0219
78 EXPOSURE VIA INGESTION 55 0.0218
79 ELECTRIC SHOCK SENSATION 61 0.0218
80 HYPOMANIA 80 0.0217
81 SINUS BRADYCARDIA 208 0.0215
82 MENOPAUSAL SYMPTOMS 50 0.0215
83 BIPOLAR I DISORDER 47 0.0214
84 PERSONALITY DISORDER 56 0.0214
85 HOSTILITY 54 0.0212
86 BRUXISM 114 0.0211
87 EUPHORIC MOOD 215 0.0210
88 HYPERLACTACIDAEMIA 56 0.0209
89 DISSOCIATION 160 0.0208
90 TOXICITY TO VARIOUS AGENTS 3482 0.0206
91 POSTURE ABNORMAL 67 0.0206
92 MYDRIASIS 263 0.0205
93 DYSLIPIDAEMIA 103 0.0203
94 LOSS OF LIBIDO 182 0.0202
95 SUICIDAL IDEATION 1842 0.0201
96 MUSCLE RIGIDITY 240 0.0200
97 URINARY TRACT DISORDER 90 0.0200
98 VENTRICULAR HYPOKINESIA 64 0.0199
99 YAWNING 53 0.0199
100 RESPIRATORY ARREST 542 0.0196
101 PULSELESS ELECTRICAL ACTIVITY 81 0.0194
102 STRESS CARDIOMYOPATHY 112 0.0192
103 HYPERTONIA 110 0.0192
104 TACHYPHRENIA 66 0.0190
105 PARKINSONISM 185 0.0190
106 HAEMORRHAGIC STROKE 148 0.0189
107 NEUROLEPTIC MALIGNANT SYNDROME 224 0.0189
108 SOCIAL AVOIDANT BEHAVIOUR 109 0.0188
109 SEDATION 493 0.0188
110 JUVENILE IDIOPATHIC ARTHRITIS 46 0.0188
111 DEPRESSION SUICIDAL 65 0.0188
112 MANIA 308 0.0187
113 SEXUAL DYSFUNCTION 219 0.0187
114 OBESITY 297 0.0186
115 CARDIO-RESPIRATORY ARREST 769 0.0184
116 BUNDLE BRANCH BLOCK RIGHT 82 0.0178
117 BRADYPHRENIA 116 0.0177
118 HALLUCINATION, AUDITORY 280 0.0176
119 METABOLIC ACIDOSIS 562 0.0176
120 NYSTAGMUS 93 0.0175
121 POTENTIATING DRUG INTERACTION 58 0.0173
122 DRUG ABUSE 1410 0.0169
123 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 70 0.0168
124 SINUS TACHYCARDIA 239 0.0168
125 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 44 0.0168
126 MATERNAL DRUGS AFFECTING FOETUS 127 0.0165
127 MUSCLE TWITCHING 380 0.0165
128 PARANOIA 284 0.0165
129 TALIPES 51 0.0164
130 HAEMODYNAMIC INSTABILITY 123 0.0161
131 RESPIRATORY ACIDOSIS 63 0.0160
132 APPETITE DISORDER 106 0.0160
133 DRUG TOXICITY 217 0.0159
134 RESTLESS LEGS SYNDROME 289 0.0159
135 SOPOR 208 0.0157
136 HALLUCINATIONS, MIXED 66 0.0157
137 SMALL FOR DATES BABY 77 0.0155
138 BLOOD PROLACTIN INCREASED 73 0.0155
139 VENTRICULAR ARRHYTHMIA 56 0.0153
140 AGITATION 1124 0.0153
141 HEART DISEASE CONGENITAL 54 0.0152
142 EYE MOVEMENT DISORDER 104 0.0152
143 LEFT VENTRICULAR HYPERTROPHY 65 0.0152
144 DRUG LEVEL INCREASED 246 0.0148
145 APATHY 216 0.0148
146 NEONATAL RESPIRATORY DISTRESS SYNDROME 52 0.0147
147 ALCOHOL USE 54 0.0146
148 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 150 0.0146
149 TRISMUS 75 0.0145
150 CHRONIC KIDNEY DISEASE 1094 0.0144
151 ABNORMAL LOSS OF WEIGHT 98 0.0144
152 HYPERPROLACTINAEMIA 93 0.0143
153 RESPIRATION ABNORMAL 98 0.0142
154 MIOSIS 114 0.0142
155 DYSTONIA 273 0.0141
156 ANXIETY DISORDER 47 0.0141
157 DEPRESSED LEVEL OF CONSCIOUSNESS 555 0.0140
158 SALIVARY HYPERSECRETION 139 0.0139
159 COMA 652 0.0137
160 END STAGE RENAL DISEASE 246 0.0135
161 ARTERIOSCLEROSIS CORONARY ARTERY 88 0.0133
162 DEPRESSED MOOD 689 0.0130
163 ACUTE RESPIRATORY DISTRESS SYNDROME 230 0.0130
164 PANIC DISORDER 50 0.0129
165 CARDIAC ARREST 1056 0.0128
166 UNRESPONSIVE TO STIMULI 329 0.0127
167 BLOOD MAGNESIUM DECREASED 110 0.0127
168 PSYCHIATRIC SYMPTOM 94 0.0127
169 AFFECTIVE DISORDER 100 0.0127
170 BLOOD LACTIC ACID INCREASED 67 0.0127
171 PANIC ATTACK 461 0.0126
172 ENURESIS 51 0.0126
173 RESTLESSNESS 462 0.0126
174 INCREASED APPETITE 241 0.0126
175 VENTRICULAR SEPTAL DEFECT 72 0.0126
176 PANIC REACTION 90 0.0125
177 GALACTORRHOEA 80 0.0124
178 TOXIC ENCEPHALOPATHY 63 0.0124
179 SNORING 47 0.0124
180 AGGRESSION 622 0.0124
181 SELF-MEDICATION 51 0.0124
182 DECREASED INTEREST 73 0.0124
183 SLEEP TERROR 52 0.0123
184 RALES 71 0.0122
185 ATRIAL SEPTAL DEFECT 102 0.0122
186 DYSKINESIA 495 0.0122
187 PERSONALITY CHANGE 112 0.0120
188 COORDINATION ABNORMAL 168 0.0120
189 ASPHYXIA 98 0.0120
190 TENSION 73 0.0120
191 ORTHOSTATIC HYPOTENSION 208 0.0119
192 ALCOHOLISM 50 0.0117
193 CONCUSSION 89 0.0115
194 COLITIS MICROSCOPIC 54 0.0114
195 DYSPHEMIA 50 0.0114
196 HYPONATRAEMIA 642 0.0114
197 VITAMIN B12 DEFICIENCY 46 0.0113
198 HOMICIDAL IDEATION 46 0.0113
199 NEUTROPHIL COUNT INCREASED 116 0.0113
200 ALTERED STATE OF CONSCIOUSNESS 244 0.0113
201 EXTRAPYRAMIDAL DISORDER 279 0.0112
202 WITHDRAWAL SYNDROME 471 0.0112
203 DRUG USE DISORDER 94 0.0112
204 HYPOTHERMIA 113 0.0112
205 DISTURBANCE IN ATTENTION 600 0.0111
206 PSYCHOTIC DISORDER 328 0.0111
207 PATENT DUCTUS ARTERIOSUS 44 0.0111
208 CHOLECYSTITIS CHRONIC 74 0.0110
209 FAECAL INCONTINENCE 53 0.0110
210 DELUSION 171 0.0110
211 CARDIOMEGALY 135 0.0110
212 PRE-ECLAMPSIA 52 0.0109
213 TACHYCARDIA 968 0.0109
214 FLANK PAIN 102 0.0109
215 GENERALISED OEDEMA 134 0.0108
216 DRUG EXPOSURE DURING PREGNANCY 366 0.0107
217 SWOLLEN TONGUE 334 0.0107
218 THINKING ABNORMAL 199 0.0107
219 POOR QUALITY SLEEP 229 0.0106
220 VENTRICULAR FIBRILLATION 118 0.0106
221 BUNDLE BRANCH BLOCK LEFT 45 0.0106
222 HYPERTHERMIA 81 0.0106
223 OCULAR DISCOMFORT 119 0.0106
224 DRUG WITHDRAWAL SYNDROME NEONATAL 156 0.0105
225 SOMNAMBULISM 69 0.0105
226 HEAD DISCOMFORT 186 0.0105
227 FORMICATION 73 0.0105
228 TREMOR 1740 0.0105
229 ANHEDONIA 275 0.0105
230 ATTENTION DEFICIT HYPERACTIVITY DISORDER 44 0.0104
231 CARDIOTOXICITY 93 0.0104
232 GRAND MAL CONVULSION 96 0.0104
233 BIPOLAR DISORDER 113 0.0104
234 DEPRESSION 2365 0.0104
235 NIGHTMARE 358 0.0103
236 BRADYKINESIA 61 0.0103
237 PNEUMONIA ASPIRATION 257 0.0103
238 HEPATIC STEATOSIS 191 0.0102
239 MENTAL STATUS CHANGES 279 0.0100
240 ATAXIA 118 0.0099
241 RHABDOMYOLYSIS 414 0.0099
242 VENTRICULAR TACHYCARDIA 163 0.0099
243 AUTISM SPECTRUM DISORDER 54 0.0098
244 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
245 CARDIOGENIC SHOCK 139 0.0097
246 BRADYCARDIA 512 0.0096
247 ASTHENOPIA 53 0.0096
248 ANGIOPATHY 54 0.0096
249 CEREBRAL DISORDER 71 0.0096
250 IRRITABILITY 577 0.0096
251 TARDIVE DYSKINESIA 270 0.0096
252 PHOTOPHOBIA 179 0.0095
253 AFFECT LABILITY 91 0.0094
254 ACUTE PULMONARY OEDEMA 53 0.0094
255 ACIDOSIS 72 0.0094
256 PSYCHOMOTOR HYPERACTIVITY 155 0.0093
257 BLOOD CHOLESTEROL ABNORMAL 43 0.0093
258 DIABETIC NEUROPATHY 46 0.0093
259 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 82 0.0093
260 CRYING 337 0.0093
261 URINARY RETENTION 308 0.0092
262 FEAR 247 0.0092
263 FEELING DRUNK 68 0.0091
264 APNOEA 71 0.0091
265 MICTURITION URGENCY 104 0.0091
266 URINARY INCONTINENCE 269 0.0091
267 BEHAVIOUR DISORDER 49 0.0090
268 HAEMATEMESIS 229 0.0090
269 ACUTE KIDNEY INJURY 1380 0.0090
270 ANXIETY 2556 0.0090
271 DROOLING 62 0.0090
272 INTESTINAL ISCHAEMIA 49 0.0089
273 MOOD SWINGS 282 0.0088
274 DYSARTHRIA 333 0.0088
275 SUBARACHNOID HAEMORRHAGE 90 0.0088
276 HYPOKALAEMIA 407 0.0088
277 PRESYNCOPE 214 0.0088
278 ABNORMAL BEHAVIOUR 345 0.0087
279 DELIRIUM 301 0.0087
280 SPINAL OSTEOARTHRITIS 76 0.0086
281 IMPAIRED QUALITY OF LIFE 124 0.0086
282 TACHYPNOEA 117 0.0086
283 SOMNOLENCE 1728 0.0086
284 ECONOMIC PROBLEM 130 0.0086
285 PSYCHOLOGICAL TRAUMA 74 0.0086
286 NEUROLOGICAL SYMPTOM 49 0.0086
287 LIVER FUNCTION TEST ABNORMAL 249 0.0086
288 HALLUCINATION, VISUAL 180 0.0085
289 POST-TRAUMATIC STRESS DISORDER 57 0.0085
290 CONFUSIONAL STATE 1373 0.0085
291 PULMONARY CONGESTION 112 0.0085
292 INITIAL INSOMNIA 87 0.0085
293 ANGER 285 0.0084
294 RENAL INJURY 250 0.0084
295 CIRCULATORY COLLAPSE 143 0.0084
296 LEUKOCYTOSIS 151 0.0083
297 ENERGY INCREASED 49 0.0083
298 BALANCE DISORDER 715 0.0083
299 PRODUCT SUBSTITUTION ISSUE 475 0.0082
300 EXERCISE TOLERANCE DECREASED 47 0.0082
301 DIPLOPIA 210 0.0081
302 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44 0.0081
303 HYPERHIDROSIS 1039 0.0081
304 DIZZINESS POSTURAL 78 0.0080
305 MENTAL DISORDER 348 0.0080
306 METABOLIC DISORDER 46 0.0079
307 LACTIC ACIDOSIS 256 0.0079
308 VENTRICULAR EXTRASYSTOLES 82 0.0079
309 SEIZURE 911 0.0079
310 TROPONIN INCREASED 60 0.0079
311 HYPERSOMNIA 226 0.0079
312 MOOD ALTERED 215 0.0079
313 TINNITUS 362 0.0079
314 HALLUCINATION 592 0.0078
315 SCREAMING 50 0.0078
316 DISORIENTATION 310 0.0078
317 ERECTILE DYSFUNCTION 200 0.0078
318 BRAIN INJURY 78 0.0078
319 ATRIOVENTRICULAR BLOCK COMPLETE 52 0.0078
320 ASPIRATION 85 0.0078
321 RENAL TUBULAR NECROSIS 76 0.0077
322 FOETAL EXPOSURE DURING PREGNANCY 628 0.0077
323 COLITIS ISCHAEMIC 52 0.0077
324 LETHARGY 441 0.0077
325 EATING DISORDER 163 0.0076
326 SCHIZOPHRENIA 93 0.0076
327 ELECTROCARDIOGRAM ABNORMAL 60 0.0076
328 MENTAL IMPAIRMENT 184 0.0076
329 BLOOD POTASSIUM DECREASED 228 0.0076
330 COGNITIVE DISORDER 354 0.0076
331 INTERVERTEBRAL DISC DEGENERATION 70 0.0076
332 BLOOD CALCIUM DECREASED 85 0.0076
333 IMPAIRED GASTRIC EMPTYING 102 0.0075
334 SLEEP DISORDER 527 0.0075
335 BRAIN FOG 116 0.0074
336 HYPERLIPIDAEMIA 88 0.0074
337 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 45 0.0073
338 GASTRITIS 191 0.0073
339 ABNORMAL DREAMS 200 0.0072
340 SENSORY LOSS 58 0.0072
341 STATUS EPILEPTICUS 81 0.0072
342 ECCHYMOSIS 49 0.0071
343 PRESCRIBED OVERDOSE 138 0.0071
344 HYPOXIA 251 0.0071
345 SPEECH DISORDER 372 0.0071
346 AMNESIA 461 0.0071
347 LOW BIRTH WEIGHT BABY 56 0.0070
348 EMOTIONAL DISORDER 217 0.0070
349 SYNCOPE 704 0.0070
350 UPPER GASTROINTESTINAL HAEMORRHAGE 118 0.0070
351 SUBSTANCE ABUSE 57 0.0070
352 SENSATION OF FOREIGN BODY 59 0.0070
353 VITAMIN D DEFICIENCY 68 0.0070
354 CAESAREAN SECTION 81 0.0070
355 HYPOKINESIA 101 0.0070
356 HYPOTENSION 1395 0.0069
357 MYOPATHY 60 0.0069
358 SUDDEN DEATH 73 0.0069
359 MYOCARDITIS 79 0.0069
360 SLEEP APNOEA SYNDROME 130 0.0068
361 MIDDLE INSOMNIA 127 0.0068
362 ENCEPHALOPATHY 167 0.0068
363 GASTROOESOPHAGEAL REFLUX DISEASE 546 0.0068
364 TUBULOINTERSTITIAL NEPHRITIS 127 0.0068
365 COLD SWEAT 119 0.0067
366 BLOOD TRIGLYCERIDES INCREASED 119 0.0067
367 HEPATOMEGALY 66 0.0067
368 HYPOTONIA 67 0.0067
369 RENAL PAIN 71 0.0067
370 BRONCHIECTASIS 45 0.0067
371 RESPIRATORY RATE INCREASED 59 0.0066
372 DRUG SCREEN POSITIVE 52 0.0066
373 SHOCK 151 0.0066
374 MEMORY IMPAIRMENT 891 0.0065
375 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 110 0.0065
376 SUPRAVENTRICULAR TACHYCARDIA 62 0.0065
377 WEIGHT INCREASED 1448 0.0065
378 FEELING JITTERY 123 0.0064
379 EAR DISCOMFORT 66 0.0064
380 NERVOUSNESS 335 0.0064
381 SPINAL PAIN 75 0.0064
382 ARTERIOSCLEROSIS 60 0.0064
383 IMMUNODEFICIENCY 95 0.0064
384 RENAL FAILURE 844 0.0063
385 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 305 0.0063
386 HYPOCALCAEMIA 120 0.0063
387 ANAL INCONTINENCE 57 0.0063
388 TENDERNESS 66 0.0063
389 OVERDOSE 1363 0.0063
390 DYSPHONIA 369 0.0063
391 CHOLECYSTECTOMY 72 0.0063
392 TRICUSPID VALVE INCOMPETENCE 50 0.0063
393 INSOMNIA 1675 0.0063
394 BLOOD CREATINE PHOSPHOKINASE INCREASED 181 0.0063
395 LOSS OF CONSCIOUSNESS 803 0.0063
396 LEUKAEMIA 59 0.0062
397 PRODUCT ADMINISTRATION INTERRUPTED 49 0.0062
398 HYSTERECTOMY 54 0.0062
399 FALL 2072 0.0062
400 HEAVY MENSTRUAL BLEEDING 56 0.0062
401 OBSTRUCTIVE AIRWAYS DISORDER 69 0.0062
402 APHASIA 187 0.0062
403 PULMONARY OEDEMA 277 0.0062
404 POST PROCEDURAL INFECTION 50 0.0061
405 DYSURIA 226 0.0061
406 OESOPHAGITIS 67 0.0061
407 DECREASED ACTIVITY 66 0.0061
408 EJECTION FRACTION DECREASED 95 0.0061
409 MUSCLE TIGHTNESS 99 0.0061
410 TONGUE DISORDER 44 0.0061
411 HEMIPARESIS 103 0.0061
412 SLUGGISHNESS 62 0.0061
413 BODY TEMPERATURE INCREASED 124 0.0061
414 HAIR DISORDER 50 0.0061
415 MYOCARDIAL ISCHAEMIA 69 0.0061
416 INTENTIONAL PRODUCT MISUSE 529 0.0060
417 RASH PUSTULAR 44 0.0060
418 ARRHYTHMIA 286 0.0060
419 LIP SWELLING 201 0.0060
420 SWELLING FACE 393 0.0060
421 HIATUS HERNIA 78 0.0060
422 WRIST FRACTURE 72 0.0060
423 NEPHROPATHY 56 0.0060
424 POLYURIA 49 0.0060
425 FACIAL PARALYSIS 51 0.0060
426 RIB FRACTURE 123 0.0060
427 VITAMIN D DECREASED 51 0.0060
428 TREATMENT NONCOMPLIANCE 326 0.0060
429 PALPITATIONS 696 0.0059
430 OSTEOPENIA 90 0.0059
431 PHARYNGEAL SWELLING 58 0.0059
432 ACTIVITIES OF DAILY LIVING IMPAIRED 117 0.0059
433 BREAST PAIN 63 0.0059
434 HYPERCHOLESTEROLAEMIA 57 0.0059
435 GASTROENTERITIS 86 0.0059
436 BLOOD SODIUM DECREASED 111 0.0059
437 BLOOD CHOLESTEROL INCREASED 273 0.0059
438 ACCIDENTAL OVERDOSE 214 0.0058
439 HYPOGLYCAEMIA 283 0.0058
440 DRY MOUTH 473 0.0058
441 PREMATURE BABY 175 0.0058
442 CONGENITAL ANOMALY 45 0.0058
443 TOOTH FRACTURE 64 0.0058
444 THERAPY CHANGE 57 0.0058
445 WHITE BLOOD CELL COUNT INCREASED 221 0.0058
446 HYPOMAGNESAEMIA 80 0.0057
447 PHARMACEUTICAL PRODUCT COMPLAINT 149 0.0057
448 CHOLELITHIASIS 188 0.0057
449 PRODUCT ODOUR ABNORMAL 60 0.0057
450 HEPATOCELLULAR INJURY 81 0.0057
451 SPINAL DISORDER 54 0.0057
452 TOOTH ABSCESS 58 0.0057
453 CONDITION AGGRAVATED 1730 0.0057
454 MEDICATION ERROR 316 0.0057
455 FOOT FRACTURE 107 0.0056
456 ATRIAL FLUTTER 45 0.0056
457 TYPE 2 DIABETES MELLITUS 189 0.0056
458 MULTIPLE ORGAN DYSFUNCTION SYNDROME 159 0.0056
459 BODY HEIGHT DECREASED 60 0.0056
460 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 307 0.0056
461 ELECTROLYTE IMBALANCE 65 0.0056
462 NEURALGIA 136 0.0056
463 ATELECTASIS 54 0.0056
464 ANGIOEDEMA 247 0.0056
465 HAEMATURIA 191 0.0056
466 ATRIOVENTRICULAR BLOCK 43 0.0056
467 PARAESTHESIA 873 0.0055
468 CARDIOMYOPATHY 82 0.0055
469 LUNG INFILTRATION 49 0.0055
470 CHOLECYSTITIS 66 0.0055
471 CONVULSION 316 0.0055
472 HYPOPHAGIA 141 0.0055
473 VERTIGO 336 0.0055
474 INTENTIONAL DRUG MISUSE 115 0.0055
475 HEAD INJURY 174 0.0055
476 JOINT DISLOCATION 58 0.0055
477 PHARYNGITIS 68 0.0055
478 DYSSTASIA 160 0.0055
479 DIABETES MELLITUS INADEQUATE CONTROL 97 0.0055
480 ASCITES 161 0.0055
481 DEFORMITY 51 0.0055
482 MUSCLE SPASTICITY 67 0.0054
483 MALNUTRITION 61 0.0054
484 PARALYSIS 78 0.0054
485 INCREASED TENDENCY TO BRUISE 50 0.0054
486 MUSCULAR WEAKNESS 617 0.0054
487 DENTAL CARIES 60 0.0054
488 NIGHT SWEATS 174 0.0054
489 EPILEPSY 165 0.0054
490 EMPHYSEMA 54 0.0053
491 FIBROMYALGIA 130 0.0053
492 MIGRAINE 509 0.0053
493 MOVEMENT DISORDER 171 0.0053
494 POLLAKIURIA 222 0.0053
495 INCONTINENCE 56 0.0053
496 SENSORY DISTURBANCE 85 0.0053
497 DYSPEPSIA 520 0.0053
498 URINARY TRACT INFECTION 900 0.0053
499 FEEDING DISORDER 107 0.0053
500 GALLBLADDER DISORDER 94 0.0053
501 PRODUCTIVE COUGH 251 0.0053
502 DIABETIC KETOACIDOSIS 126 0.0052
503 BLINDNESS 212 0.0052
504 MULTIPLE SCLEROSIS RELAPSE 356 0.0052
505 NOCTURIA 63 0.0052
506 INJURY 363 0.0052
507 NECK PAIN 288 0.0051
508 URINE OUTPUT DECREASED 45 0.0051
509 GAIT DISTURBANCE 984 0.0051
510 HEART RATE IRREGULAR 116 0.0051
511 GASTROINTESTINAL INFECTION 46 0.0051
512 DIABETES MELLITUS 391 0.0051
513 RESPIRATORY FAILURE 374 0.0051
514 INTERNATIONAL NORMALISED RATIO INCREASED 146 0.0051
515 LEUKOPENIA 256 0.0051
516 JOINT INJURY 109 0.0051
517 MUSCULOSKELETAL STIFFNESS 447 0.0051
518 DEVELOPMENTAL DELAY 46 0.0051
519 VOMITING 2397 0.0051
520 VISION BLURRED 700 0.0051
521 PHOTOSENSITIVITY REACTION 84 0.0051
522 STEVENS-JOHNSON SYNDROME 113 0.0051
523 SCIATICA 81 0.0051
524 HYPOAESTHESIA 759 0.0051
525 PARAESTHESIA ORAL 73 0.0051
526 CONTUSION 487 0.0051
527 MUSCLE ATROPHY 64 0.0050
528 THERAPY NON-RESPONDER 227 0.0050
529 DRUG WITHDRAWAL SYNDROME 443 0.0050
530 HAEMATOCRIT DECREASED 100 0.0050
531 HYPERTENSION 1068 0.0050
532 BLOOD GLUCOSE FLUCTUATION 55 0.0050
533 RETCHING 107 0.0050
534 DIZZINESS 2499 0.0050
535 MOTOR DYSFUNCTION 51 0.0050
536 NO THERAPEUTIC RESPONSE 61 0.0050
537 ABORTION INDUCED 47 0.0050
538 HAIR COLOUR CHANGES 62 0.0050
539 PURPURA 44 0.0050
540 AMENORRHOEA 87 0.0050
541 DISEASE RECURRENCE 236 0.0050
542 PRODUCT PRESCRIBING ERROR 118 0.0049
543 PRURITUS GENERALISED 107 0.0049
544 ACUTE RESPIRATORY FAILURE 95 0.0049
545 RESPIRATORY DISTRESS 136 0.0049
546 MULTI-ORGAN FAILURE 85 0.0049
547 IMPAIRED WORK ABILITY 105 0.0049
548 ANKLE FRACTURE 76 0.0049
549 ABDOMINAL PAIN 1140 0.0049
550 CYANOSIS 77 0.0049
551 LACERATION 46 0.0049
552 ANGINA PECTORIS 140 0.0049
553 RENAL FAILURE ACUTE 207 0.0049
554 CHEST DISCOMFORT 499 0.0049
555 THIRST 87 0.0049
556 HAEMATOMA 126 0.0049
557 ADRENAL INSUFFICIENCY 59 0.0049
558 HYPERTENSIVE CRISIS 54 0.0048
559 IRRITABLE BOWEL SYNDROME 104 0.0048
560 DYSPNOEA EXERTIONAL 182 0.0048
561 DECREASED APPETITE 1121 0.0048
562 MELAENA 106 0.0048
563 PERIPHERAL COLDNESS 66 0.0048
564 PANCREATITIS ACUTE 108 0.0048
565 FAECES DISCOLOURED 104 0.0048
566 JAUNDICE 129 0.0048
567 DECREASED IMMUNE RESPONSIVENESS 47 0.0048
568 OSTEOARTHRITIS 203 0.0048
569 PANCREATITIS 253 0.0048
570 FEELING HOT 293 0.0048
571 CHILLS 559 0.0048
572 MATERNAL EXPOSURE DURING PREGNANCY 425 0.0048
573 IRON DEFICIENCY ANAEMIA 44 0.0048
574 CHEST PAIN 882 0.0048
575 IMPAIRED DRIVING ABILITY 54 0.0047
576 TEMPERATURE INTOLERANCE 49 0.0047
577 ACUTE MYOCARDIAL INFARCTION 140 0.0047
578 PULMONARY FIBROSIS 91 0.0047
579 CHROMATURIA 107 0.0047
580 ABASIA 117 0.0047
581 ROAD TRAFFIC ACCIDENT 198 0.0047
582 CARPAL TUNNEL SYNDROME 66 0.0047
583 LOWER RESPIRATORY TRACT INFECTION 214 0.0047
584 COELIAC DISEASE 46 0.0047
585 BRAIN OEDEMA 59 0.0047
586 FEELING COLD 130 0.0047
587 GAIT INABILITY 156 0.0047
588 PULMONARY EMBOLISM 443 0.0047
589 ALANINE AMINOTRANSFERASE INCREASED 285 0.0046
590 OSTEOMYELITIS 84 0.0046
591 FEELING ABNORMAL 1111 0.0046
592 MOBILITY DECREASED 333 0.0046
593 HEADACHE 2904 0.0046
594 BLOOD ALKALINE PHOSPHATASE INCREASED 115 0.0046
595 EAR PAIN 90 0.0046
596 THERAPY CESSATION 237 0.0046
597 HAEMORRHOIDS 90 0.0046
598 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 79 0.0046
599 ROTATOR CUFF SYNDROME 59 0.0046
600 MITRAL VALVE INCOMPETENCE 52 0.0046
601 UPPER RESPIRATORY TRACT INFECTION 212 0.0046
602 MADAROSIS 53 0.0046
603 HYPERKALAEMIA 160 0.0046
604 MOUTH ULCERATION 96 0.0046
605 HYPERGLYCAEMIA 166 0.0046
606 BLOOD PRESSURE INCREASED 696 0.0045
607 HEPATIC CYTOLYSIS 58 0.0045
608 TOXIC EPIDERMAL NECROLYSIS 69 0.0045
609 INTERVERTEBRAL DISC PROTRUSION 99 0.0045
610 BLOOD PRESSURE ABNORMAL 90 0.0045
611 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 236 0.0045
612 OSTEOPOROSIS 186 0.0045
613 INFLUENZA LIKE ILLNESS 372 0.0045
614 MULTIPLE SCLEROSIS 216 0.0045
615 EOSINOPHILIA 79 0.0045
616 MASS 63 0.0045
617 BACK INJURY 49 0.0045
618 HEART RATE INCREASED 446 0.0045
619 HAIR TEXTURE ABNORMAL 60 0.0045
620 MALAISE 1961 0.0045
621 MYALGIA 759 0.0045
622 WHEEZING 264 0.0044
623 SEPSIS 494 0.0044
624 ISCHAEMIC STROKE 79 0.0044
625 LOWER LIMB FRACTURE 85 0.0044
626 PHARYNGEAL OEDEMA 68 0.0044
627 BEDRIDDEN 58 0.0044
628 LYMPHOCYTE COUNT DECREASED 78 0.0044
629 NEPHROLITHIASIS 201 0.0044
630 ABNORMAL WEIGHT GAIN 54 0.0044
631 APHONIA 61 0.0044
632 BLOOD PRESSURE DECREASED 290 0.0044
633 EXPOSURE DURING PREGNANCY 271 0.0044
634 EYE SWELLING 162 0.0044
635 NAUSEA 3431 0.0043
636 DYSPHAGIA 411 0.0043
637 ABDOMINAL PAIN UPPER 890 0.0043
638 OROPHARYNGEAL PAIN 399 0.0043
639 JOINT STIFFNESS 113 0.0043
640 WEIGHT DECREASED 1202 0.0043
641 PALLOR 117 0.0043
642 TENDON RUPTURE 53 0.0043
643 DEEP VEIN THROMBOSIS 277 0.0043
644 PNEUMONITIS 116 0.0043
645 FATIGUE 3313 0.0043
646 DRUG DISPENSING ERROR 65 0.0042
647 BLOOD PRESSURE FLUCTUATION 102 0.0042
648 HYPERBILIRUBINAEMIA 44 0.0042
649 MUSCULOSKELETAL DISCOMFORT 73 0.0042
650 FOOT DEFORMITY 47 0.0042
651 CYSTITIS 135 0.0042
652 PELVIC PAIN 77 0.0042
653 SKIN LACERATION 46 0.0042
654 PULMONARY HYPERTENSION 88 0.0042
655 CHOKING 82 0.0042
656 ORAL PAIN 94 0.0042
657 MUSCLE SPASMS 768 0.0042
658 DRUG INTOLERANCE 404 0.0042
659 DISCOMFORT 255 0.0042
660 ASTHENIA 1571 0.0042
661 GASTRIC ULCER 79 0.0042
662 THYROID DISORDER 64 0.0041
663 OEDEMA PERIPHERAL 506 0.0041
664 SPINAL FRACTURE 83 0.0041
665 OXYGEN SATURATION DECREASED 232 0.0041
666 LIVER INJURY 101 0.0041
667 THROAT TIGHTNESS 111 0.0041
668 QUALITY OF LIFE DECREASED 55 0.0041
669 SEASONAL ALLERGY 58 0.0041
670 HERNIA 79 0.0041
671 COAGULOPATHY 68 0.0041
672 DEHYDRATION 541 0.0041
673 INFLUENZA 452 0.0040
674 NERVE INJURY 45 0.0040
675 EYE PAIN 228 0.0040
676 NASAL CONGESTION 237 0.0040
677 PULMONARY MASS 60 0.0040
678 ACUTE HEPATIC FAILURE 55 0.0040
679 HYPOTHYROIDISM 128 0.0040
680 LIMB DISCOMFORT 124 0.0040
681 BONE DISORDER 73 0.0040
682 NEUROTOXICITY 70 0.0040
683 HEPATIC CIRRHOSIS 75 0.0040
684 ABDOMINAL DISTENSION 416 0.0040
685 HIP FRACTURE 128 0.0040
686 KIDNEY INFECTION 78 0.0040
687 NERVOUS SYSTEM DISORDER 124 0.0040
688 DYSPNOEA 2247 0.0040
689 RECTAL HAEMORRHAGE 170 0.0040
690 PSORIATIC ARTHROPATHY 160 0.0039
691 SKIN LESION 108 0.0039
692 BACK DISORDER 64 0.0039
693 CENTRAL NERVOUS SYSTEM LESION 54 0.0039
694 HAEMOPTYSIS 109 0.0039
695 DEAFNESS 102 0.0039
696 SMALL INTESTINAL OBSTRUCTION 48 0.0039
697 DERMATITIS ALLERGIC 49 0.0039
698 GLAUCOMA 75 0.0039
699 PYREXIA 1342 0.0039
700 CONSTIPATION 844 0.0039
701 CELLULITIS 195 0.0039
702 ABORTION SPONTANEOUS 155 0.0039
703 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275 0.0039
704 INTERSTITIAL LUNG DISEASE 187 0.0039
705 BRONCHITIS 285 0.0038
706 FREQUENT BOWEL MOVEMENTS 104 0.0038
707 CLOSTRIDIUM DIFFICILE INFECTION 84 0.0038
708 DIARRHOEA 2468 0.0038
709 HEPATOTOXICITY 85 0.0038
710 TOOTHACHE 69 0.0038
711 ASPARTATE AMINOTRANSFERASE INCREASED 202 0.0038
712 HYPOAESTHESIA ORAL 57 0.0038
713 PAIN IN EXTREMITY 1113 0.0038
714 DERMATITIS 79 0.0038
715 SINUSITIS 385 0.0038
716 SPLENOMEGALY 44 0.0038
717 THROAT IRRITATION 167 0.0037
718 RASH MACULAR 130 0.0037
719 THERAPY PARTIAL RESPONDER 58 0.0037
720 EPISTAXIS 278 0.0037
721 HEPATITIS 95 0.0037
722 SEPTIC SHOCK 161 0.0037
723 COUGH 1037 0.0037
724 RHINORRHOEA 239 0.0037
725 ACCIDENT 44 0.0037
726 C-REACTIVE PROTEIN INCREASED 134 0.0037
727 ORAL DISCOMFORT 51 0.0037
728 EMOTIONAL DISTRESS 444 0.0037
729 GASTROENTERITIS VIRAL 66 0.0037
730 FLATULENCE 207 0.0036
731 DYSGEUSIA 271 0.0036
732 BACK PAIN 842 0.0036
733 FLUSHING 368 0.0036
734 PRODUCT PHYSICAL ISSUE 73 0.0036
735 PNEUMONIA 1168 0.0036
736 MUSCULOSKELETAL PAIN 189 0.0036
737 SWELLING 337 0.0036
738 PRODUCT USE IN UNAPPROVED INDICATION 892 0.0036
739 FEMUR FRACTURE 111 0.0036
740 EAR INFECTION 95 0.0036
741 ANKYLOSING SPONDYLITIS 47 0.0036
742 TOOTH INFECTION 47 0.0036
743 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
744 HEART RATE DECREASED 125 0.0036
745 TRANSIENT ISCHAEMIC ATTACK 120 0.0036
746 SINUS CONGESTION 48 0.0035
747 LIMB INJURY 96 0.0035
748 ARTHRALGIA 1469 0.0035
749 STAPHYLOCOCCAL INFECTION 116 0.0035
750 GINGIVAL BLEEDING 48 0.0035
751 CORONARY ARTERY DISEASE 106 0.0035
752 PAIN IN JAW 99 0.0035
753 ANOREXIA 45 0.0035
754 CEREBRAL HAEMORRHAGE 125 0.0035
755 MUSCULOSKELETAL CHEST PAIN 54 0.0035
756 COMPLICATION OF DEVICE REMOVAL 63 0.0035
757 PLEURAL EFFUSION 212 0.0035
758 DEMENTIA 97 0.0035
759 HYPERSENSITIVITY 643 0.0035
760 UPPER LIMB FRACTURE 69 0.0035
761 TRANSAMINASES INCREASED 77 0.0035
762 ARTHRITIS 272 0.0035
763 ASTHMA 390 0.0034
764 PREGNANCY 69 0.0034
765 PAIN 2114 0.0034
766 BLOOD PRESSURE SYSTOLIC INCREASED 67 0.0034
767 OEDEMA 186 0.0034
768 RENAL IMPAIRMENT 288 0.0034
769 VIRAL INFECTION 114 0.0034
770 BLOOD URINE PRESENT 65 0.0034
771 ABDOMINAL DISCOMFORT 574 0.0034
772 SKIN DISCOLOURATION 157 0.0034
773 AGEUSIA 85 0.0034
774 HOT FLUSH 256 0.0034
775 LUNG DISORDER 166 0.0034
776 CHOLESTASIS 65 0.0034
777 FACE OEDEMA 57 0.0034
778 GENERAL PHYSICAL HEALTH DETERIORATION 391 0.0034
779 PSORIASIS 441 0.0034
780 PRODUCT ADMINISTRATION ERROR 68 0.0034
781 CATARACT 200 0.0034
782 CORONARY ARTERY OCCLUSION 46 0.0034
783 DRUG-INDUCED LIVER INJURY 105 0.0033
784 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86 0.0033
785 PRODUCT DOSE OMISSION 217 0.0033
786 RED BLOOD CELL COUNT DECREASED 95 0.0033
787 TENDONITIS 51 0.0033
788 GASTROINTESTINAL HAEMORRHAGE 275 0.0033
789 TOOTH DISORDER 73 0.0033
790 POST PROCEDURAL COMPLICATION 63 0.0033
791 VAGINAL HAEMORRHAGE 142 0.0033
792 DRUG RESISTANCE 84 0.0033
793 BACTERIAL INFECTION 61 0.0033
794 ATRIAL FIBRILLATION 318 0.0033
795 BLOOD CREATININE INCREASED 213 0.0033
796 INTENTIONAL DOSE OMISSION 93 0.0033
797 BONE PAIN 191 0.0033
798 SNEEZING 73 0.0033
799 SKIN ULCER 84 0.0032
800 CONTRAINDICATED PRODUCT ADMINISTERED 98 0.0032
801 HEPATIC FAILURE 97 0.0032
802 MENORRHAGIA 63 0.0032
803 ULCER 51 0.0032
804 INFLAMMATION 165 0.0032
805 LOCALISED INFECTION 77 0.0032
806 SINUS DISORDER 63 0.0032
807 BURNING SENSATION 223 0.0032
808 ANAEMIA 606 0.0032
809 RASH PRURITIC 172 0.0032
810 MULTIPLE FRACTURES 52 0.0032
811 HUNGER 44 0.0032
812 LOCAL SWELLING 55 0.0031
813 WOUND 88 0.0031
814 RASH MACULO-PAPULAR 70 0.0031
815 BASAL CELL CARCINOMA 49 0.0031
816 INSURANCE ISSUE 48 0.0031
817 CANDIDA INFECTION 53 0.0031
818 GLYCOSYLATED HAEMOGLOBIN INCREASED 79 0.0031
819 DRY EYE 156 0.0031
820 METRORRHAGIA 53 0.0031
821 BLOOD UREA INCREASED 52 0.0031
822 TASTE DISORDER 63 0.0031
823 TREATMENT FAILURE 257 0.0031
824 GASTROINTESTINAL DISORDER 277 0.0031
825 FLUID OVERLOAD 45 0.0031
826 PNEUMOTHORAX 49 0.0031
827 ADVERSE DRUG REACTION 277 0.0031
828 IMPAIRED HEALING 101 0.0031
829 RESPIRATORY DISORDER 92 0.0031
830 RESPIRATORY TRACT INFECTION 80 0.0031
831 COLITIS 116 0.0031
832 JOINT SWELLING 368 0.0030
833 HAEMATOCHEZIA 168 0.0030
834 VISUAL ACUITY REDUCED 101 0.0030
835 COVID-19 533 0.0030
836 SCAR 52 0.0030
837 VISUAL IMPAIRMENT 376 0.0030
838 DISABILITY 60 0.0030
839 THERAPEUTIC RESPONSE UNEXPECTED 136 0.0030
840 OFF LABEL USE 2642 0.0030
841 LABORATORY TEST ABNORMAL 89 0.0030
842 PRURITUS 1158 0.0030
843 FLUID RETENTION 153 0.0030
844 PERIPHERAL SWELLING 463 0.0030
845 ERUCTATION 58 0.0030
846 DRUG EFFECT DECREASED 161 0.0030
847 PRODUCT DISPENSING ERROR 65 0.0030
848 ECZEMA 156 0.0030
849 LIVER DISORDER 132 0.0030
850 HAEMOGLOBIN DECREASED 305 0.0030
851 PRODUCT DOSE OMISSION IN ERROR 84 0.0030
852 ARTHROPATHY 164 0.0029
853 LYMPHADENOPATHY 104 0.0029
854 ANAPHYLACTIC REACTION 162 0.0029
855 RASH ERYTHEMATOUS 140 0.0029
856 CARDIAC FAILURE CONGESTIVE 235 0.0029
857 INTENTIONAL PRODUCT USE ISSUE 256 0.0029
858 DRUG INEFFECTIVE 3845 0.0029
859 COMPLICATION OF DEVICE INSERTION 58 0.0029
860 PERICARDIAL EFFUSION 67 0.0029
861 ALOPECIA 564 0.0029
862 INTESTINAL OBSTRUCTION 108 0.0029
863 URTICARIA 480 0.0029
864 DRUG PRESCRIBING ERROR 55 0.0029
865 THERAPEUTIC RESPONSE DECREASED 173 0.0029
866 NEUTROPHIL COUNT DECREASED 116 0.0028
867 SURGERY 166 0.0028
868 DERMATITIS ATOPIC 149 0.0028
869 DRUG DOSE OMISSION 467 0.0028
870 WHITE BLOOD CELL COUNT DECREASED 306 0.0028
871 GASTRIC DISORDER 96 0.0028
872 COLITIS ULCERATIVE 124 0.0028
873 NASOPHARYNGITIS 511 0.0028
874 PRESCRIBED UNDERDOSE 55 0.0028
875 BLISTER 154 0.0027
876 PROCEDURAL PAIN 76 0.0027
877 SKIN DISORDER 91 0.0027
878 MENSTRUATION IRREGULAR 73 0.0027
879 UNEVALUABLE EVENT 206 0.0027
880 BLOOD POTASSIUM INCREASED 44 0.0027
881 NEUTROPENIA 368 0.0027
882 RASH GENERALISED 70 0.0027
883 ILLNESS 278 0.0027
884 ABDOMINAL PAIN LOWER 68 0.0027
885 PRODUCT USE ISSUE 503 0.0027
886 THERAPY INTERRUPTED 191 0.0027
887 INFECTION 384 0.0027
888 CARDIAC FAILURE 212 0.0026
889 DRUG DEPENDENCE 423 0.0026
890 EYE DISORDER 86 0.0026
891 THROMBOSIS 210 0.0026
892 GLOSSODYNIA 58 0.0026
893 PRODUCT QUALITY ISSUE 350 0.0026
894 CARDIAC DISORDER 241 0.0026
895 DIVERTICULITIS 71 0.0026
896 BLOOD GLUCOSE DECREASED 123 0.0026
897 DRUG EFFECT INCOMPLETE 93 0.0026
898 CARDIOVASCULAR DISORDER 65 0.0026
899 HEPATIC ENZYME INCREASED 174 0.0025
900 HAEMORRHAGE 265 0.0025
901 WRONG TECHNIQUE IN DRUG USAGE PROCESS 92 0.0025
902 BONE DENSITY DECREASED 79 0.0025
903 RENAL DISORDER 117 0.0025
904 DRUG ADMINISTRATION ERROR 77 0.0025
905 EYE PRURITUS 84 0.0025
906 DEVICE BREAKAGE 101 0.0025
907 INJECTION SITE MASS 92 0.0025
908 PANCYTOPENIA 139 0.0025
909 RHEUMATOID ARTHRITIS 282 0.0025
910 UNDERDOSE 177 0.0024
911 KNEE ARTHROPLASTY 51 0.0024
912 SKIN EXFOLIATION 204 0.0024
913 HYPOACUSIS 104 0.0024
914 TOOTH LOSS 50 0.0024
915 RASH 1051 0.0024
916 BLOOD BILIRUBIN INCREASED 65 0.0024
917 LACRIMATION INCREASED 72 0.0024
918 PRODUCT DOSE OMISSION ISSUE 699 0.0024
919 INJECTION SITE PRURITUS 159 0.0024
920 CONJUNCTIVITIS 44 0.0024
921 PRODUCT AVAILABILITY ISSUE 54 0.0024
922 AGRANULOCYTOSIS 44 0.0024
923 CEREBROVASCULAR ACCIDENT 400 0.0024
924 ORAL HERPES 46 0.0024
925 CEREBRAL INFARCTION 57 0.0023
926 BLOOD GLUCOSE ABNORMAL 43 0.0023
927 EYE IRRITATION 134 0.0023
928 ILL-DEFINED DISORDER 141 0.0023
929 HERPES ZOSTER 133 0.0023
930 THROMBOCYTOPENIA 258 0.0023
931 STOMATITIS 139 0.0023
932 FUNGAL INFECTION 75 0.0022
933 PRODUCT PRESCRIBING ISSUE 49 0.0022
934 MYOCARDIAL INFARCTION 384 0.0022
935 NEEDLE ISSUE 64 0.0022
936 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 156 0.0022
937 LIVER FUNCTION TEST INCREASED 47 0.0022
938 NEUROPATHY PERIPHERAL 207 0.0022
939 INCORRECT PRODUCT ADMINISTRATION DURATION 47 0.0022
940 ANAPHYLACTIC SHOCK 55 0.0021
941 THERAPEUTIC RESPONSE SHORTENED 70 0.0021
942 RASH PAPULAR 47 0.0021
943 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 371 0.0021
944 INJECTION SITE REACTION 141 0.0020
945 DEVICE DISLOCATION 89 0.0020
946 PLATELET COUNT DECREASED 218 0.0020
947 ERYTHEMA 419 0.0020
948 INFUSION RELATED REACTION 135 0.0020
949 INJECTION SITE ERYTHEMA 247 0.0020
950 INCORRECT DOSE ADMINISTERED 443 0.0019
951 BLOOD GLUCOSE INCREASED 355 0.0019
952 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
953 PAIN OF SKIN 50 0.0019
954 THERAPEUTIC PRODUCT EFFECT DECREASED 82 0.0018
955 ADVERSE EVENT 168 0.0018
956 OSTEONECROSIS OF JAW 45 0.0018
957 DEATH 1563 0.0018
958 INJECTION SITE BRUISING 144 0.0018
959 HOSPITALISATION 275 0.0018
960 INJECTION SITE PAIN 548 0.0018
961 DRY SKIN 236 0.0018
962 OCULAR HYPERAEMIA 83 0.0017
963 INJECTION SITE SWELLING 132 0.0017
964 GYNAECOMASTIA 53 0.0017
965 INCORRECT DRUG ADMINISTRATION DURATION 48 0.0017
966 DISEASE PROGRESSION 200 0.0017
967 APPLICATION SITE ERYTHEMA 44 0.0017
968 PRODUCT ADHESION ISSUE 59 0.0016
969 HEPATIC FUNCTION ABNORMAL 61 0.0016
970 DEVICE ISSUE 144 0.0016
971 ACNE 121 0.0016
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 310 0.0015
973 DEVICE EXPULSION 99 0.0015
974 INJECTION SITE HAEMORRHAGE 117 0.0015
975 LUNG NEOPLASM MALIGNANT 59 0.0014
976 DEVICE MALFUNCTION 100 0.0014
977 OSTEONECROSIS 46 0.0014
978 EXPIRED PRODUCT ADMINISTERED 45 0.0014
979 NEOPLASM MALIGNANT 89 0.0013
980 PLASMA CELL MYELOMA 52 0.0013
981 BREAST CANCER 123 0.0013
982 SKIN IRRITATION 60 0.0013
983 NEOPLASM PROGRESSION 44 0.0013
984 FEBRILE NEUTROPENIA 82 0.0012
985 SKIN BURNING SENSATION 84 0.0012
986 MALIGNANT NEOPLASM PROGRESSION 115 0.0011
987 DEVICE LEAKAGE 48 0.0011
988 DEPENDENCE 58 0.0011
989 NO ADVERSE EVENT 176 0.0010
990 ACCIDENTAL EXPOSURE TO PRODUCT 100 0.0010
991 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 45 0.0010
992 PRODUCT STORAGE ERROR 61 0.0007
993 DRUG DOSE OMISSION BY DEVICE 51 0.0007